Lixisenatide and PD Lixisenatide is another GLP-1 RA indicated for the treatment of T2DM
Cardio (Aerobic Exercise) : Activities like running, cycling, swimming, and HIIT (high-intensity interval training) are great for burning calories and improving heart health
Realistic expectations : Understanding that these medications work best as part of a comprehensive approach to health, not as a quick fix
The initial analysis revealed there is considerable uncertainty about the payback from the weight loss from GLP-1s
Doctors typically recommend this treatment when: An individual has not experienced significant weight loss through lifestyle changes alone
The measures included: Appendicular and trunk fat-free mass (proxy for lean muscle) Whole-body and trunk fat mass Body-fat percentage Waist-to-hip ratio Key Findings The researchers found that for every 1-unit reduction in BMI linked to GLP-1 mimicry: Fat mass decreased by ~7.9 kg Lean mass (muscle) decreased by ~6.4 kg Body-fat percentage dropped by ~4.5% In other words, fat loss exceeded muscle loss in both absolute and relative terms, which supports the use of GLP-1 drugs as a viable treatment for obesity